A Stock Overview
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 6/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A from our risk checks.
Agilent Technologies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$133.84 |
52 Week High | US$155.35 |
52 Week Low | US$124.10 |
Beta | 1.07 |
11 Month Change | 2.80% |
3 Month Change | -4.73% |
1 Year Change | 5.70% |
33 Year Change | -11.99% |
5 Year Change | 65.71% |
Change since IPO | 213.08% |
Recent News & Updates
Recent updates
Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly
Oct 21With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case
Sep 23Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues
Sep 09Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Aug 23A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Aug 14Agilent: Making A Move To Ignite Some Growth
Jul 25Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet
Jul 15Is Agilent A Buy Before Earnings? Examining The Pros And Cons
May 23Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?
May 22Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price
May 07These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Dec 07Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25Shareholder Returns
A | US Life Sciences | US Market | |
---|---|---|---|
7D | 5.3% | 2.8% | 2.2% |
1Y | 5.7% | 2.9% | 31.6% |
Return vs Industry: A exceeded the US Life Sciences industry which returned 2.9% over the past year.
Return vs Market: A underperformed the US Market which returned 31.7% over the past year.
Price Volatility
A volatility | |
---|---|
A Average Weekly Movement | 3.6% |
Life Sciences Industry Average Movement | 8.5% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: A has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: A's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 17,400 | Padraig McDonnell | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
A fundamental statistics | |
---|---|
Market cap | US$38.46b |
Earnings (TTM) | US$1.41b |
Revenue (TTM) | US$6.50b |
27.2x
P/E Ratio5.9x
P/S RatioIs A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A income statement (TTM) | |
---|---|
Revenue | US$6.50b |
Cost of Revenue | US$2.96b |
Gross Profit | US$3.53b |
Other Expenses | US$2.12b |
Earnings | US$1.41b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Nov 25, 2024
Earnings per share (EPS) | 4.92 |
Gross Margin | 54.39% |
Net Profit Margin | 21.75% |
Debt/Equity Ratio | 49.7% |
How did A perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield19%
Payout RatioDoes A pay a reliable dividends?
See A dividend history and benchmarksAgilent Technologies dividend dates | |
---|---|
Ex Dividend Date | Dec 31 2024 |
Dividend Pay Date | Jan 22 2025 |
Days until Ex dividend | 36 days |
Days until Dividend pay date | 58 days |
Does A pay a reliable dividends?
See A dividend history and benchmarks